News

"As society continues to grapple with the consequences of violent behaviors, increasing efforts to understand and mitigate the risks of such behaviors using evidence-based methods and tools will be essential."

Today, spread peace.

Today is World Alzheimer's Day!

The investigators noted fast, clinically meaningful, and sustained improvements in symptoms of depression and related functional impairment.

Welcome to the Emergency Psychiatry Special Report.

The drug’s developer announced that the FDA has made 2 clarifying revisions.

Do SSRIs impact on the antidepressant efficacy of psilocybin? Researchers performed an open-label trial of single-dose psilocybin in patients with TRD who were taking SSRIs.

An estimated 31% of physicians have been sued at some point in their careers. Here's what you need to know.

Is excess imprisonment a uniquely American problem?

Here’s what the historic case of the Genain quadruplets reveals about some deeper, uncomfortable truths about American society.

An expert discusses the connections between the 2 highly comorbid diseases and some ways to effectively treat both diseases simultaneously.

How can we ensure that diversity, equity, inclusion, and access are truly achieved in clinical trials industry-wide?

"For months she has dreamed in red..."

Awarding laughter… check out these past Ig Nobel Prize winners.

From the efficacy of adjunctive TMS for treatment-resistant major depression to a look at adult ADHD, here are highlights from the week in Psychiatric Times.

The presentation of schizophrenia differs significantly between men and women. Here's what you need to know.

What is new in research on psychiatric care for Latinx patient populations?

September 15 to October 15 is Hispanic Heritage Month. To celebrate, here’s a look at some recent coverage in Psychiatric Times® on how clinicians can improve psychiatric care for Latinx patients.

Arts and psychiatry: better at collaboration than most.

What 10 things do you need to know before entering a job interview?

As we say goodbye to summer…

What astonishes you?

"Collaborative care quality initiatives may have become an insurance industry buzzword, but the true spirit of collaborating to save lives has always lived within clinicians."

An expert discusses recent research evaluating a selective M4 positive allosteric modulator for the treatment of schizophrenia.

Let’s take another look at telepsychiatry.

Adjunctive rTMS for treatment-resistant depression? Researchers performed a meta-analysis of 19 randomized sham-controlled trials.

Have you registered for the 2023 Annual Psychiatric Times World CME Conference?

Have you ever had a patient die by suicide?

"The history of psychiatry is a history of fads in theory, diagnosis, and treatment. Such rapid shifts in conceptualization—such as the emergence of the concept of adult ADHD—almost always warrant informed critical examination."

“Our findings might inform PTSD pathology, treatment plans, and future disaster-response strategies.”